Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy
NCT05265819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2026-05-01
Summary
Effect of exergaming exercises and mediteranean diet on thyroid cancer patients following total thyroidectomy adult patients from both gender will be randomly assigned equally to exergaming exercises, Mediterranean diet groups using computer-generated block randomization.
Group A: Control group No intervention was provided for 12 weeks except thyroid hormone replacement therapy Group B: Exergaming exercise The volunteers carried out 36 exergaming sessions, with progressive increase in the duration of the games according to their tolerance,and reached a maximum duration of 50 minutes per session, included the realization of the games and the rest between activities. The exergaming protocol was performed three times a week, for a total of 12 weeks Group C: Mediterranean diet All participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.PREDIMED questionnaire is used To assess adherence to the Mediterranean diet Group D: Exergaming exercises and Mediterranean diet Exergaming exercises are used in addition to Mediterranean diet
Conditions
Interventions
- DEVICE
-
X-BOX kinetic360
1\) Exergaming The practice of exergaming was performed using the Xbox 360 Kinect console,The volunteers carried out 36 exergaming sessions, with progressive increase in the duration of the games according to their tolerance,and reached a maximum duration of 50 minutes per session, included the realization of the games and the rest between activities. The exergaming protocol was performed two to three times a week, for a total of 12 weeks.
- DIETARY_SUPPLEMENT
-
mediterranean diet
Mediterranean diet participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.
- DRUG
-
thyroid hormone replacement therapy
thyroid hormone replacement therapy
Sponsors & Collaborators
-
Nabil Mahmoud Ismail Abdel-Aal
lead OTHER
Principal Investigators
-
Mohsen Elsayyad, PhD · Professor
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2025-07-05
- Completion
- 2025-07-05
Countries
- Egypt
More Related Trials
-
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
NCT00812149 ·Status: COMPLETED
-
Thyroid and Glucose and Energy Metabolism
NCT00106119 ·Status: COMPLETED ·Phase: PHASE2
-
The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females
NCT06377943 ·Status: COMPLETED
-
The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients
NCT00080574 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
NCT00196729 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of Molecular Biomarkers for Thyroid Cancer
NCT04133870 ·Status: UNKNOWN
-
Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer
NCT01744769 ·Status: UNKNOWN
-
Classic Total Thyroidectomy With or Without Drains
NCT00691990 ·Status: COMPLETED ·Phase: NA
-
Thyroid Cancer in United Arab Emirates
NCT04763122 ·Status: COMPLETED
-
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
NCT06853925 ·Status: RECRUITING ·Phase: NA
-
Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism
NCT04146259 ·Status: COMPLETED
-
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
NCT03841617 ·Status: RECRUITING ·Phase: PHASE2
-
ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease
NCT06960005 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT01707056 ·Status: WITHDRAWN ·Phase: NA
-
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
NCT05247476 ·Status: UNKNOWN ·Phase: PHASE4
-
Exercise Capacity, Physical Activity Levels in Patients With Hyperthyroid
NCT04825964 ·Status: COMPLETED
-
Study of Usefulness of Fluorescence in Thiroid Surgery
NCT06011369 ·Status: UNKNOWN ·Phase: NA
-
Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery
NCT02548715 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Effects of Low-Level Laser Therapy on Oxidative Stress Levels
NCT04754607 ·Status: COMPLETED ·Phase: NA
-
Alterations in Quality of Life After Thyroidectomy for Benign Thyroid Disease
NCT03566537 ·Status: COMPLETED
-
Thyroid Disease Serum Repository
NCT00592605 ·Status: COMPLETED
-
Studies on Tumors of the Thyroid
NCT00001160 ·Status: RECRUITING
-
Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism
NCT02317926 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Change of Thyroid Antibodies on Hormone Level and Disease Burden in Patients With Hashimoto's Thyroiditis
NCT07048821 ·Status: COMPLETED ·Phase: NA
-
Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
NCT00749697 ·Status: UNKNOWN ·Phase: NA